Subjects (N) | sBcl-2 (ng/ml) | sFas (pg/ml) | sTRAIL (pg/ml) | sFasL (ng/ml) |
---|---|---|---|---|
JDM (34) | 34.5±26.7*(4.3–110.4) | 126.2±78.1 (22.9–293.7) | 435.4±385.0 (69.9–1695.8) | 0.32 |
Healthy controls (40) | 10.3±10.4 (2.0–37.7) | 133.2±80.6 (53.7–472.2) | 338.0±247.7 (69.5–1023.9) | 0.4±0.4 (0.02–1.4) |
JIA (33, disease controls) | 23.9±37.2 (0.9–136.4) | 166.7±84.3 (25.3–319.3) | 429.5±406.6 (104.3–1975.4) | 0.3±0.4 (0.01–1.1) |
JSLE (31, disease controls) | 8.2±9.7 (1.9–38.3) | 186.8±69.7**(40.5–349.0) | 794.1±665.7**(115.2–2917.6) | 0.08±0.1** (0.01–0.4) |
↵* Mean ± SD and range. p<0.05, JDM vs healthy controls.
** p<0.05, JSLE vs healthy controls. Kruskal-Wallis test.